BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 27764108)

  • 1. Identification and Characterization of VNI/VNII and Novel VNII/VNIV Hybrids and Impact of Hybridization on Virulence and Antifungal Susceptibility Within the C. neoformans/C. gattii Species Complex.
    Aminnejad M; Cogliati M; Duan S; Arabatzis M; Tintelnot K; Castañeda E; Lazéra M; Velegraki A; Ellis D; Sorrell TC; Meyer W
    PLoS One; 2016; 11(10):e0163955. PubMed ID: 27764108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII.
    Aminnejad M; Diaz M; Arabatzis M; Castañeda E; Lazera M; Velegraki A; Marriott D; Sorrell TC; Meyer W
    Mycopathologia; 2012 Jun; 173(5-6):337-46. PubMed ID: 22081254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and geographical distribution of genotypes and mating types of Cryptococcus neoformans and Cryptococcus gattii species complexes in Argentina.
    Taverna CG; Bosco-Borgeat ME; Mazza M; Vivot ME; Davel G; Canteros CE;
    Rev Argent Microbiol; 2020; 52(3):183-188. PubMed ID: 31948732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties.
    Ngamskulrungroj P; Gilgado F; Faganello J; Litvintseva AP; Leal AL; Tsui KM; Mitchell TG; Vainstein MH; Meyer W
    PLoS One; 2009 Jun; 4(6):e5862. PubMed ID: 19517012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
    Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
    Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular typing and antifungal susceptibility of clinical isolates of Cryptococcus neoformans and Cryptococcus gattii species complexes from the National Invasive Fungal Surveillance Network of Uruguay.
    Puime CA; Bórmida V; Pan D
    Med Mycol; 2023 Jul; 61(7):. PubMed ID: 37336574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population diversity and virulence characteristics of Cryptococcus neoformans/C. gattii species complexes isolated during the pre-HIV-pandemic era.
    Pharkjaksu S; Kwon-Chung KJ; Bennett JE; Ngamskulrungroj P
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008651. PubMed ID: 33017391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex.
    Firacative C; Trilles L; Meyer W
    PLoS One; 2012; 7(5):e37566. PubMed ID: 22666368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular-Type Specific Multiplex PCR produces a distinct VNII PCR pattern among Cryptococcus neoformans species complex.
    Cogliati M; Andrianarivelo MR; Ellabib M; Nnadi EN; Cornet M
    Med Mycol; 2019 Apr; 57(3):384-386. PubMed ID: 29762748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Vitek MS for Differentiation of
    Siqueira LPM; Gimenes VMF; de Freitas RS; Melhem MSC; Bonfietti LX; da Silva AR; Souza Santos LB; Motta AL; Rossi F; Benard G; de Almeida JN
    J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30429250
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.
    González GM; Casillas-Vega N; Garza-González E; Hernández-Bello R; Rivera G; Rodríguez JA; Bocanegra-Garcia V
    Folia Microbiol (Praha); 2016 Jan; 61(1):51-6. PubMed ID: 26109075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Aller AI; Canton E; Castañón-Olivares LR; Chowdhary A; Cordoba S; Cuenca-Estrella M; Fothergill A; Fuller J; Govender N; Hagen F; Illnait-Zaragozi MT; Johnson E; Kidd S; Lass-Flörl C; Lockhart SR; Martins MA; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Pfaller MA; Schell WA; St-Germain G; Trilles L; Turnidge J
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5898-906. PubMed ID: 22948877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility.
    Liaw SJ; Wu HC; Hsueh PR
    Clin Microbiol Infect; 2010 Jun; 16(6):696-703. PubMed ID: 19694765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypes and population genetics of cryptococcus neoformans and cryptococcus gattii species complexes in Europe and the mediterranean area.
    Cogliati M; Desnos-Ollivier M; McCormick-Smith I; Rickerts V; Ferreira-Paim K; Meyer W; Boekhout T; Hagen F; Theelen B; Inácio J; Alonso B; Colom MF; Trilles L; Montagna MT; De Donno A; Susever S; Ergin C; Velegraki A; Ellabib MS; Nardoni S; Macci C; Trovato L; Dipineto L; Akcaglar S; Mlinaric-Missoni E; Bertout S; Vencá ACF; Sampaio AC; Criseo G; Ranque S; Çerikçioğlu N; Marchese A; Vezzulli L; Ilkit M; Pasquale V; Polacheck I; Lockhart SR
    Fungal Genet Biol; 2019 Aug; 129():16-29. PubMed ID: 30953839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility.
    Lee GA; Arthur I; Merritt A; Leung M
    Med Mycol; 2019 Nov; 57(8):1004-1010. PubMed ID: 30649538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F; Hare Jensen R; Meis JF; Arendrup MC
    Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic analysis of clinical and environmental Cryptococcus neoformans isolates from Brazil reveals the presence of VNB isolates and a correlation with biological factors.
    Andrade-Silva LE; Ferreira-Paim K; Ferreira TB; Vilas-Boas A; Mora DJ; Manzato VM; Fonseca FM; Buosi K; Andrade-Silva J; Prudente BDS; Araujo NE; Sales-Campos H; da Silva MV; Júnior VR; Meyer W; Silva-Vergara ML
    PLoS One; 2018; 13(3):e0193237. PubMed ID: 29505557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multilocus sequence typing (MLST) and M13 PCR fingerprinting revealed heterogeneity amongst Cryptococcus species obtained from Italian veterinary isolates.
    Danesi P; Firacative C; Cogliati M; Otranto D; Capelli G; Meyer W
    FEMS Yeast Res; 2014 Sep; 14(6):897-909. PubMed ID: 24981157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology reveals genetic diversity amongst isolates of the Cryptococcus neoformans/C. gattii species complex in Thailand.
    Kaocharoen S; Ngamskulrungroj P; Firacative C; Trilles L; Piyabongkarn D; Banlunara W; Poonwan N; Chaiprasert A; Meyer W; Chindamporn A
    PLoS Negl Trop Dis; 2013; 7(7):e2297. PubMed ID: 23861989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil.
    Trilles L; Lazéra Mdos S; Wanke B; Oliveira RV; Barbosa GG; Nishikawa MM; Morales BP; Meyer W
    Mem Inst Oswaldo Cruz; 2008 Aug; 103(5):455-62. PubMed ID: 18797758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.